Abstract
Inflammatory signaling networks play critical roles in the interpretation and processing of external and internal challenges encountered by living organisms. Consequently, alterations in various inflammatory processes are linked with almost all human diseases, and provide important clues for potential pharmacological intervention. Macrophages and CD4 T helper cells are central modulators within the inflammatory network. Both cells can adopt distinct phenotypes and activation status depending upon their environments. Consequently, they are critically involved in the progression as well as attenuation of various inflammatory processes. This review will highlight recent progress in our understanding toward the complex activation and differentiation of macrophages and CD4 T helper cells and their involvement in inflammation. Furthermore, we will discuss potential cellular and molecular targets within the inflammatory network for pharmacological intervention of human inflammatory diseases.
Keywords: Inflammatory networks, Macrophage activation, T helper cell differentiation, inflammatory diseases
Current Signal Transduction Therapy
Title: Inflammatory Signaling Networks as Targets for Pharmacological Intervention of Chronic Diseases
Volume: 4 Issue: 2
Author(s): Urmila Maitra, Samantha M. Baglin and Liwu Li
Affiliation:
Keywords: Inflammatory networks, Macrophage activation, T helper cell differentiation, inflammatory diseases
Abstract: Inflammatory signaling networks play critical roles in the interpretation and processing of external and internal challenges encountered by living organisms. Consequently, alterations in various inflammatory processes are linked with almost all human diseases, and provide important clues for potential pharmacological intervention. Macrophages and CD4 T helper cells are central modulators within the inflammatory network. Both cells can adopt distinct phenotypes and activation status depending upon their environments. Consequently, they are critically involved in the progression as well as attenuation of various inflammatory processes. This review will highlight recent progress in our understanding toward the complex activation and differentiation of macrophages and CD4 T helper cells and their involvement in inflammation. Furthermore, we will discuss potential cellular and molecular targets within the inflammatory network for pharmacological intervention of human inflammatory diseases.
Export Options
About this article
Cite this article as:
Maitra Urmila, Baglin M. Samantha and Li Liwu, Inflammatory Signaling Networks as Targets for Pharmacological Intervention of Chronic Diseases, Current Signal Transduction Therapy 2009; 4 (2) . https://dx.doi.org/10.2174/157436209788167510
DOI https://dx.doi.org/10.2174/157436209788167510 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Rational Approach on the Use of Sex Steroids in Multiple Sclerosis
Recent Patents on CNS Drug Discovery (Discontinued) Mesenchymal Stromal Cell Secretome: Immunomodulation, Tissue Repair and Effects on Neurodegenerative Conditions
Current Stem Cell Research & Therapy Humanized Cobra Venom Factor: Experimental Therapeutics for Targeted Complement Activation and Complement Depletion
Current Pharmaceutical Design Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Current Drug Metabolism Estrogen Receptor Neurobiology and its Potential for Translation into Broad Spectrum Therapeutics for CNS Disorders
Current Molecular Pharmacology Drug Discovery in Enteroviral Infections
Infectious Disorders - Drug Targets Reporting Rates of Yellow Fever Vaccine 17D or 17DD-Associated Serious Adverse Events in Pharmacovigilance Data Bases: Systematic Review
Current Drug Safety Varicella-Zoster Virus Infections During Pregnancy: Epidemiology, Clinical Symptoms, Diagnosis, Prevention and Therapy
Current Pediatric Reviews Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics
Medicinal Chemistry Selective Activation of Intracellular Signalling Pathways in Dendritic Cells for Cancer Immunotherapy
Anti-Cancer Agents in Medicinal Chemistry High Dose Immunoglobulin (IVIG) May Reduce the Incidence of Langerhans Cell Histiocytosis (LCH)-Associated Central Nervous System Involvement
CNS & Neurological Disorders - Drug Targets Nanotechnology in Therapeutics – Current Technologies and Applications
Current Nanoscience CNS Drug Delivery Systems: Novel Approaches
Recent Patents on Drug Delivery & Formulation New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design Sympathetic Nervous System Dysfunction in Multiple Sclerosis, Linking Neurodegeneration to a Reduced Response to Therapy
Current Pharmaceutical Design Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis
Current Pharmaceutical Design Kainic Acid-Induced Neurotoxicity: Targeting Glial Responses and Glia-Derived Cytokines
Current Neuropharmacology Editorial (Thematic Issue: Global Trends in Nanotechnological Approaches for Various Health Issues – Volume II)
Current Drug Metabolism Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
Current Molecular Medicine Designing Peptide Mimetics for the Treatment of Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry